Benzinga's Top Upgrades, Downgrades For March 8, 2018

Top Upgrades

• Baird upgraded Parker-Hannifin Corp PH from Neutral to Outperform. Parker Hannifin shares fell 0.82 percent to close at $176.39 on Wednesday.
• Longbow Research upgraded Wendys Co WEN from Neutral to Buy. Wendy's shares rose 1.92 percent to $16.95 in pre-market trading.
• Argus upgraded Booking Holdings Inc. BKNG from Hold to Buy. Booking Holdings shares rose 1.79 percent to close at $2,122.93 on Wednesday.
• Analysts at Raymond James upgraded Quidel Corporation QDEL from Outperform to Strong Buy. Quidel rose 4.88 percent to close at $46.88 on Wednesday.
• UBS upgraded Baker Hughes, a GE company BHGE from Neutral to Buy. Baker Hughes shares rose 1.52 percent to $29.36 in pre-market trading.
• Goldman Sachs upgraded Barclays PLC (ADR) BCS from Sell to Neutral. Barclays shares fell 0.08 percent to $11.80 in pre-market trading.
• RBC Capital upgraded Pinnacle West Capital Corporation PNW from Sector Perform to Outperform. Pinnacle West Capital shares fell 1.14 percent to close at $75.43 on Wednesday.
• Analysts at Goldman Sachs upgraded Microchip Technology Inc. MCHP from Neutral to Buy. Microchip Technology shares rose 1.50 percent to $97.00 in pre-market trading.
• Argus upgraded Splunk Inc SPLK from Hold to Buy. Splunk shares rose 2.05 percent to $107.82 in pre-market trading.
• Barclays upgraded Dollar Tree, Inc. DLTR from Equal-Weight to Overweight. Dollar Tree shares rose 0.84 percent to $90.00 in pre-market trading.

Top Downgrades

• Analysts at B. Riley downgraded Zagg Inc ZAGG from Buy to Neutral. Zagg shares fell 10.32 percent to $13.90 in pre-market trading.
• Maxim Group downgraded THL Credit, Inc. TCRD from Buy to Hold. THL Credit shares fell 3.28 percent to $7.97 in pre-market trading.
• UBS downgraded HubSpot Inc HUBS from Buy to Neutral. HubSpot shares fell 1.21 percent to $118.55 in pre-market trading.
• Leerink Swann downgraded American Renal Associates Holdings Inc ARA from Outperform to Market Perform. American Renal Associates shares closed at $23.52 on Wednesday.
• Craig-Hallum downgraded CalAmp Corp. CAMP from Buy to Hold. CalAmp shares fell 0.65 percent to $24.60 in pre-market trading.
• Keefe Bruyette & Woods downgraded United Financial Bancorp Inc UBNK from Outperform to Market Perform. United Financial Bancorp shares rose 0.50 percent to close at $15.94 on Wednesday.

Top Initiations

• UBS initiated coverage on Connecticut Water Service Inc CTWS with a Neutral rating. The price target for Connecticut Water Service is set to $53. Connecticut Water Service shares closed at $50.34 on Wednesday.
• Barclays initiated coverage on McKesson Corporation MCK with an Equal-Weight rating. The price target for McKesson is set to $165. McKesson shares closed at $151.75 on Wednesday.
• H.C. Wainwright initiated coverage on Interpace Diagnostics Group Inc IDXG with a Buy rating. The price target for Interpace Diagnostics is set to $3. Interpace Diagnostics shares closed at $1.01 on Wednesday.
• UBS initiated coverage on American Water Works Company Inc AWK with a Buy rating. The price target for American Water Works is set to $89. American Water Works shares closed at $80.18 on Wednesday.
• H.C. Wainwright initiated coverage on Genocea Biosciences Inc GNCA with a Buy rating. The price target for Genocea Biosciences is set to $5. Genocea Biosciences shares closed at $1.11 on Wednesday.
• Analysts at Barclays initiated coverage on UnitedHealth Group Inc UNH with an Overweight rating. The price target for UnitedHealth is set to $265. UnitedHealth shares closed at $227.27 on Wednesday.
• Analysts at UBS initiated coverage on American States Water Co AWR with a Sell rating. The price target for American States Water is set to $42. American States Water closed at $51.51 on Wednesday.
• Analysts at JMP Securities assumed coverage on Intellia Therapeutics Inc NTLA with a Market Outperform rating. The price target for Intellia Therapeutics is set to $76. Intellia Therapeutics shares closed at $29.43 on Wednesday.
• Barclays initiated coverage on Walgreens Boots Alliance Inc WBA with an Equal-Weight rating. The price target for Walgreens is set to $76. Walgreens shares closed at $69.50 on Wednesday.